Access disease-level, longitudinal, oncology patient data to inform life science research, development, and commercial strategies with Vantage.
From R&D to post marketing and HEOR, Vantage helps oncology biopharma teams identify opportunities and create enterprise level strategies for specific cancer diagnoses.
Conduct Phase IV and HEOR studies and optimize commercial strategy.
COTA’s database of patients includes longitudinal treatment and outcomes data for oncology patients including:
Explore our collection of clinical research, recent press, podcasts, and more.
COTA’s scientific contributions have once again been recognized by the American Society of Hematology (ASH) Annual Meeting and Exposition, one...
Medical oncologist and real-world data leader succeeds Miruna Sasu, whose leadership expanded COTA’s impact across life sciences. A Leader Rooted...
Cancer is an insidious disease. Even after surgery or aggressive systemic therapy, malignant cells often take refuge in hard-to-identify places...
Discover the power of real-world cancer data for your life science organization.
